Treatment may prevent Alzheimer's cognitive decline

A new study in mice found that a treatment involving antibodies to Dkk1, a protein linked to amyloid formation in Alzheimer's patients, may protect memory by stopping the disintegration of brain synapses. It won't be useful in people who already have advanced Alzheimer's disease but could potentially slow the rate of cognitive deterioration in those in the early stages of the disease.

View Full Article in:

Independent (London) (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health